BB-201(Bright Biologics)

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameBB-201(Bright Biologics)
Drug Alias NameBB-201(Bright Biologics)BB-201
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payload +[4] 
Mechanisms of ActionAnti-HER2Anti-Trop-2Tubulin inhibitors
TargetsReceptor protein-tyrosine kinase erbB-2Tumor-associated calcium signal transducer 2Tubulin
Therapy Area/IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBright Biologics LLC
China Registration ClassN/A

Develop Information

Active CompaniesBright Biologics LLC
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A